Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies

Leukemia

Volumn 19, Issue 2, 2005, Pages 245-252

  Odero, M D ^a   Grand, F H ^b   Iqbal, S ^b   Ross, F ^b   Roman, J P ^a   Vizmanos, J L ^a   Andrieux, J ^c   Lai J L ^c   Calasanz, M J ^a   Cross, N C P ^b,d  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c Institut de Recherche sur le Cancer de Lille   (France)

^d SALISBURY DISTRICT HOSPITAL   (United Kingdom)

Author keywords

HMGA2; MDS; MDS MPD

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANEMIA; ARTICLE; B LYMPHOCYTE; BASOPHILIA; BLOOD CELL COUNT; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CARCINOGENESIS; CHROMOSOME 11Q; CHROMOSOME 12P; CHROMOSOME 12Q; CHROMOSOME 14Q; CHROMOSOME 20Q; CHROMOSOME 7P; CHROMOSOME ANALYSIS; CHROMOSOME BAND; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DISEASE COURSE; EXON; FEMALE; FIBROSIS; GENE OVEREXPRESSION; GENE SEQUENCE; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTROPHY; INTRON; KARYOTYPE 46,XX; KARYOTYPE 46,XY; KARYOTYPE 47,XXX; KARYOTYPING; MALE; MALIGNANT NEOPLASTIC DISEASE; METAPHASE CHROMOSOME; MYELODYSPLASIA; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; REFRACTORY ANEMIA WITH EXCESS BLASTS; SPLENOMEGALY;

EID: 13544270235     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403605     Document Type: Article

References (42)

1. Grosschedl R, Giese K, Pagel J. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet 1994; 10: 94-100.
2. Reeves R. Molecular biology of HMGA proteins: hubs of nuclear function. Gene 2001; 277: 63-81.
3. Grasser KD. Chromatin-associated HMGA and HMGB proteins: verstaile co-regulators of DNA-dependent processes. Plant Mol Biol 2003; 53: 281-295.
4. Reeves R, Nissen MS. The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J Biol Chem 1990; 265: 8573-8582.
5. Thanos D, Maniatis T. In vitro assembly of enhancer complexes. Methods Enzymol 1996; 274: 162-173.
6. John S, Reeves RB, Lin JX, Child R, Leiden JM, Thompson CB et al. Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins. Mol Cell Biol 1995; 15: 1786-1796.
7. Leger H, Sock E, Renner K, Grummt F, Wegner M. Functional interaction between the POU domain protein Tst-1/Oct-6 and the high-mobility-group protein HMG-I/Y. Mol Cell Biol 1995; 15: 3738-3747.
8. Schoenmakers EF, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJ. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet 1995; 10: 436-444.
9. Chiappetta G, Bandiera A, Berlingieri MT, Visconti R, Manfioletti G, Battista S et al. The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene 1995; 10: 1307-1314.
10. Giancotti V, Buratti E, Perissin L, Zorzet S, Balmain A, Portella G et al. Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp Cell Res 1989; 184: 538-545.
11. Vallone D, Battista S, Pierantoni GM, Fedele M, Casalino L, Santoro M et al. Neoplastic transformation of rat thyroid cell requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J 1997; 16: 5310-5321.
12. Zhou X, Benson KF, Ashar HR, Chada K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 1995; 376: 771-774.
13. Zhou X, Benson KF, Przybysz K, Liu J, Hou Y, Cherath L et al. Genomic structure and expression of the murine HMGI-C gene. Nucleic Acids Res 1996; 24: 4071-4077.
14. Hirning-Folz U, Wilda M, Rippe V, Bullerdiek J, Hameister H. The expression pattern of the Hmgic gene during development. Genes Chromosomes Cancer 1998; 23: 350-357.
15. Petit MM, Mols R, Schoenmakers EF, Mandahl N, Van de Ven WJ. LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family. Genomics 1996; 36: 118-129.
16. Petit MM, Schoenmakers EF, Huysmans C, Geurts JM, Mandahl N, Van de Ven WJ. LHFP, a novel translocation partner gene of HMGIC in a lipoma, is a member of a new family of LHFP-like genes. Genomics 1999; 57: 438-441.
17. Broberg K, Zhang M, Strombeck B, Isaksson M, Nilsson M, Mertens F et al. Fusion of RDC1 with HMGA2 in lipomas as the result of chromosome aberrations involving 2q35-37 and 12q13-15. Int J Oncol 2002; 21: 321-326.
18. Ashar HR, Fejzo MS, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S et al. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 1995; 82: 57-65.
19. Geurts JM, Schoenmakers EF, Van de Ven WJ. Molecular characterization of a complex chromosomal rearrangement in a pleomorphic salivary gland adenoma involving the 3′-UTR of HMGIC. Cancer Genet Cytogenet 1997; 95: 198-205.
20. Geurts JM, Schoenmakers EF, Roijer E, Stenman G, Van de Ven WJ. Expression of reciprocal hybrid transcripts of HMGIC and FHIT in a pleomorphic adenoma of the parotid gland. Cancer Res 1997; 57 13-17.
21. Geurts JM, Schoenmakers EF, Roijer E, Astrom AK, Stenman G, van de Ven WJ. Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas. Oncogene 1998; 16: 865-872.
22. Kools PF, Van de Ven WJ. Amplification of a rearranged form of the high-mobility group protein gene HMGIC in OsA-Cl osteosarcoma cells. Cancer Genet Cytogenet 1996; 91: 1-7.
23. Kazmierczak B, Hennig Y, Wanschura S, Rogalla P, Bartnitzke S, Van de Ven W et al. Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene. Cancer Res 1995; 55: 6038-6039.
24. Schoenmakers EF, Huysmans C, Van de Ven WJ. Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12;14) uterine leiomyomas. Cancer Res 1999; 59: 19-23.
25. Kurose K, Mine N, Doi D, Ota Y, Yoneyama K, Konishi H et al. Novel gene fusion of COX6C at 8q22-23 to HMGIC at 12q15 in a uterine leiomyoma. Genes Chromosomes Cancer 2000; 27: 303-307.
26. Mine N, Kurose K, Konishi H, Araki T, Nagai H, Emi M. Fusion of a sequence from HEI10 (14q11) to the HMGIC gene at 12q15 in a uterine leiomyoma. Jpn J Cancer Res 2001; 92: 135-139.
27. Pierantoni GM, Santulli B, Caliendo I, Pentimalli F, Chiappetta G, Zanesi N et al. HMGA2 locus rearrangement in a case of acute lymphoblastic leukemia. Int J Oncol 2003; 23: 363-367.
28. Andrieux J, Demory JL, Dupriez B, Quief S, Plantier I, Roumier C et al. Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia. Genes Chromosomes Cancer 2004; 39: 82-87.
29. Quade BJ, Weremowicz S, Neskey DM, Vanni R, Ladd C, Dal Cin P et al. Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15. Cancer Res 2003; 63: 1351-1358.
30. Arlotta P, Tai AK, Manfioletti G, Clifford C, Jay G, Ono SJ. Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas. J Biol Chem 2000; 275: 14394-14400.
31. Battista S, Fidanza V, Fedele M, Klein-Szanto AJ, Outwater E, Brunner H et al. The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res 1999; 59: 4793-4797.
32. Fedele M, Berlingieri MT, Scala S, Chiariotti L, Viglietto G, Rippel V et al. Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts. Oncogene 1998; 17: 413-418.
33. Fedele M, Battista S, Kenyon L, Baldassarre G, Fidanza V, Klein-Szanto AJ et al. Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene 2002; 21: 3190-3198.
34. Ashar HR, Tkachenko A, Shah P, Chada K. HMGA2 is expressed in an allele-specific manner in human lipomas. Cancer Genet Cytogenet 2003; 143: 160-168.
35. Santulli B, Kazmierczak B, Napolitano R, Caliendo I, Chiappetta G, Rippe V et al. A 12q13 translocation involving the HMGI-C gene in Richter transformation of a chronic lymphocytic leukemia. Cancer Genet Cytogenet 2000; 119: 70-73.
36. Borrmann L, Wilkening S, Bullerdiek J. The expression of HMGA genes is regulated by their 3′UTR. Oncogene 2001; 20: 4537-4541.
37. Noro B, Licheri B, Sgarra R, Rustighi A, Tessari MA, Chau KY et al. Molecular dissection of the architectural transcription factor HMGA2. Biochemistry 2003; 42: 4569-4577.
38. Ingraham SE, Lynch RA, Kathiresan S, Buckler AJ, Menon AG. hREC2, a RAD51-like gene, is disrupted by t(12;14)(q15;q24.1) in a uterine leiomyoma. Cancer Genet Cytogenet 1999; 115: 56-61.
39. Takahashi T, Nagai N, Oda H, Ohama K, Kamada N, Miyagawa K. Evidence for RAD51L1/HMGIC fusion in the pathogenesis of uterine leiomyoma. Genes Chromosomes Cancer 2001; 30: 196-201.
40. Gross KL, Neskey DM, Manchanda N, Weremowicz S, Kleinman MS, Nowak RA et al. HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies. Genes Chromosomes Cancer 2003; 38: 68-79.
41. Tessari MA, Gostissa M, Altamura S, Sgarra R, Rustighi A, Salvagno C et al. Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2. Mol Cell Biol 2003; 23: 9104-9116.
42. Borrmann L, Schwanbeck R, Heyduk T, Seebeck B, Rogalla P, Bullerdiek J et al. High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity. Nucleic Acids Res 2003; 31: 6841-6851.